Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis

BMJ

Volumn 317, Issue 7159, 1998, Pages 632-637

  de Ferranti, Sarah D ^a   Ioannidis, John P A ^a   Lau, Joseph ^a   Anninger, William V ^a   Barza, Michael ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BRODIMOPRIM; COTRIMOXAZOLE; KELFIPRIM;

ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; DRUG EFFICACY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUSITIS; TREATMENT FAILURE; TREATMENT OUTCOME;

ACUTE DISEASE; AMOXICILLIN; ANTI-BACTERIAL AGENTS; FOLIC ACID ANTAGONISTS; HUMANS; PENICILLINS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS; SINUSITIS; TREATMENT OUTCOME;

EID: 0032486944     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.317.7159.632     Document Type: Article

References (52)

1. Gwaltney JM. Sinusitis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice ofi nfectious diseases. 4th ed. Edinburgh: Churchill Livingstone, 1995: 585.
2. De Bock GH, Dekker FW, Stolk J, Springer MP, Kievit J, van Houwelinge JC. Antimicrobial treatment in acute maxillary sinusitis: am eta-analysis. J Clin Epidemiol 1997; 50: 881–890
3. American Society for Microbiology. Program anda bstracts of the interscience conference on antimicrobial agents andc hemotherapy. Washington, DC: American Society for Microbiology, 1993, 1994, 1995, 1996, 1997.
4. Jadad AR, Moore A, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinicalt rials: is blinding necessary? Control Clin Trials 1996; 17: 1–12
5. Mantel N, Haenszel W. Statistical aspects of thea nalysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719–748
6. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993; 2: 121–145
7. Lau J, Ioannidis JPA, Schmid CH. Quantitative methodsf or systematic reviews. Ann Intern Med 1997; 127: 820–826
8. Laird NM, Mosteller F. Some statistical methods forc ombining experimental results. Int J Technol Assess Health Care 1990; 6: 5–30
9. Soderstrom M, Blomberg J, Christensen P, Hovelius B. Erythromycin and phenoxymethylpenicillin (penicillin V) in the treatment ofr espiratory tract infections as related to microbiological findings and serum C-reactive protein. Scand J Infect Dis 1991; 23: 347–354
10. Alvart R. An open multicentre study to compare thee fficacy and safety of sultamicillin with that of cefuroxime axetil in acutee ar, nose and throat infections in adults. J Int Med Res 1992; 20(suppl 1): 53–61A
11. Falser N, Mittermayer H, Weuta H. Antibacterialt reatment of otitis and sinusitis with ciprofloxacin and penicillin V—a comparison. Infection 1988; 16(suppl 1): S51–S54
12. Johnson SE, Ford RD. Cephalexin dosage in generalp ractice assessed by double-blind trial. Curr Med Res Opin 1972; 1: 37–48
13. Podvinec M. Co-tetroxazin (Tibirox) und Doxycyclin (Vibramycin) in der Behandlung von Infekten der oberen Luftwege: eine Doppelblindstudie. Ther Umsch 1982; 39: 815–820
14. Axelsson A, Chidekel N, Grebelius N, Jensen C. Treatment of acute maxillary sinusitis: A comparison of four differentm ethods. Acta Otolaryngol (Stockh) 1970; 70: 71–76
15. Ganança M, Trabulsi LR. The therapeutic effects ofc yclacillin in acute sinusitis: in vitro and in vivo correlations in ap lacebo-controlled study. Curr Med Res Opin 1973; 1: 362–368
16. Wald ER, Chiponis D, Ledesma-Medina J. Comparativee ffectiveness of amoxicillin and amoxicillin-clavulanate potassium in acutep aranasal sinus infections in children: A double-blind, placebo-controlledt rial. Pediatrics 1986; 77: 795–800
17. Lindbaek M, Hjortdahl P, Johnsen ULH. Randomised,d ouble blind, placebo controlled trial of penicillin V and amoxycillin int reatment of acute sinus infections in adults. BMJ 1996; 313: 325–329
18. Van Buchem FL, Knottnerus JA, Schrijnemaekers VJJ, Peeters MF. Primary-care based randomised placebo-controlled trial ofa ntibiotic treatment in acute maxillary sinusitis. Lancet 1997; 349: 683–687
19. Stalman W, van Essen GA, van der Graaf Y, de Melker RA. The end of antibiotic treatment in adults with acute sinusitis-likec omplaints in general practice? A placebo-controlled double-blind randomizedd oxycycline trial. Br J Gen Pract 1997; 47: 794–799
20. Wald ER, Reilly JS, Casselbrant M, Ledesma-Medina J, Milmoe GJ, Bluestone CD, et al. Treatment of acute maxillary sinusitis inc hildhood: A comparative study of amoxicillin and cefaclor. J Pediatr 1984; 104: 297–302
21. Matucci KF, Levin WJ, Mohsen AH. Acute bacterials inusitis. Arch Otolaryngol Head Neck Surg 1986; 112: 73–76
22. Brodie DP, Knight S, Cunningham K. Comparative studyo f cefuroxime axetil and amoxycillin in the treatment of acute sinusitis ing eneral practice. J Int Med Res 1989; 17: 547–551
23. Casiano RR. Azithromycin and amoxicillin in thet reatment of acute maxillary sinusitis. Am J Med 1991; 91(3A): 27–30S
24. Felstead SJ, Daniel R, for the European Azithromycin Study Group. Short-course treatment of sinusitis and other upper respiratoryt ract infections with azithromycin: A comparison with erythromycin anda moxycillin. J Int Med Res 1991; 19: 363–372
25. Karma P, Pukander J, Penttila M, Ylikoski J, Savolainen S, Olen L, et al. The comparative efficacy and safety ofc larithromycin and amoxycillin in the treatment of outpatients with acutem axillary sinusitis. J Antimicrob Chemother 1991; 27(suppl A): 83–90
26. Edelstein DR, Sanford EA, Chow JM, Duerksen RL, Johnson J, Ronis M, et al. Once-a-day therapy for sinusitis: A comparisons tudy of cefixime and amoxicillin. Laryngoscope 1993; 103: 33–41
27. Huck W, Reed BD, Nielsen RW, Ferguson RT, Gray DW, Lund GK, et al. Cefaclor vs amoxicillin in the treatment of acute, recurrent,a nd chronic sinusitis. Arch Fam Med 1993; 2: 497–503
28. Calhoun KH, Hokanson JA. Multicenter comparison ofc larithromycin and amoxicillin in the treatment of acute maxillary sinusitis. Arch Fam Med 1993; 2: 837–840
29. Von Sydow C, Savolainen S, Soderqvist A. Treatment ofa cute maxillary sinusitis—comparing cefpodoxime proxetil with amoxicillin. Scand J Infec Dis 1995; 27: 229–234
30. Matthews BL, Suprax/Amoxicillin Clinical Sinusitis Study Team. Effectiveness and safety of cefixime and amoxicillin in adultsw ith acute bacterial sinusitis. In: Edlestein DR, ed. Sinusitis: optimizingm anagement strategies. A special report. Postgrad Med 1998; May: 41–9.
31. Rimmer D, Suprax/Amoxicillin Clinical Sinusitis Study Team. Efficacy of cefixime and amoxicillin in adults with acute sinusitis. In: Edlestein DR, ed. Sinusitis: optimizing management strategies. A specialr eport. Postgrad Med 1998; May: 50–7.
32. Otte J, Viada JA, Buchi MD, Slagado O. Tratamiento del os procesos sinusales agudos del adulto con tetraciclina y una combinacion des ulfametopirazina-trimethoprim. Rev Med Chile 1983; 111: 1157–1161
33. Osman MF, Menday AP. Single-blind comparison ofm iraxid and co-trimoxazole in patients with sinusitis and otitis. In: Spitzy KH, Karrer K, eds. Proceedings of the 13th International Congress of Chemotherapy. Vienna: H Egermann, 1983: 26–29. (SS 4.1/1-5.)
34. Wallace RB, Marsh BT, Talbot DJ. A multi-centreg eneral practice clinical evaluation of pivmecillinam plus pivampicillin (“Miraxid”) and co-trimoxazole (“Septrim”) in respiratory tract infections. Curr Med Res Opin 1985; 9: 659–665
35. Salmi HA, Lehtomaki K, Kylmamaa T. Comparison ofb rodimoprim and doxycycline in acute respiratory tract infections: ad ouble-blind clinical trial. Drugs Exp Clin Res 1986; 12: 349–353
36. Manzini M, Caroggio A. Efficacy and tolerability ofb rodimoprim and roxithromycin in acute sinusitis of bacterial origin ina dults. J Chemother 1993; 5: 521–525
37. Arndt J, Riebenfeld D, Maier H, Weidauer H. Therapeutic efficacy and tolerability of brodimoprim in comparison withd oxycycline in acute sinusitis in adults. J Chemother 1994; 6: 322–327
38. Bockmeyer M, Riebenfeld D, Clasen B. Controlled studyo f brodimoprim and cephalexin in the treament of patients with acute sinusitisi n general practice. Clin Ther 1994; 16: 653–661
39. Rahlfs VW, Macchiocchi A, Monti T. Brodimoprim inu pper respiratory tract infections. Clin Drug Invest 1996; 11: 65–76.
40. Hayle R, Lingaas E, Hoivik HO, Odegard T. Efficacya nd safety of azithromycin versus phenoxymethylpenicillin in the treatment ofa cute maxillary sinusitis. Eur J Clin Microbiol Infect Dis 1996; 15: 849–853
41. Schultz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associatedw ith estimates of treatment effects in controlled trials. JAMA 1995; 273: 408–412
42. Hamory BH, Sande MA, Sydnor A, Seale DL, Gwaltney JM. Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis 1979; 139: 197–202
43. Nyffeneger R, Riebenfeld D, Macciocchi A. Brodimoprimv ersus amoxicillin in the treatment of acute sinusitis. Clin Ther 1991; 13: 589–595
44. Skelton R, Maixner W, Isaacs D. Sinusitis-induceds ubdural empyema. Arch Dis Child 1992; 67: 1478–1480
45. Johnson DL, Markle BM, Wiedermann BL, Hanahan L. Treatment of intracranial abscesses associated with sinusitis in children anda dolescents. J Pediatr 1988; 113: 15–23
46. Evans FO, Sydnor JB, Morre WE, Moore GR, Manwaring JL, Brill AH, et al. Sinusitis of the maxillary antrum. N Engl J Med 1975; 293: 735–739
47. Williams JW, Holleman DR, Samsa GP, Simel DL. Randomized controlled trial of 3 vs. 10 days oft rimethoprim/sulfamethoxazole for acute maxillary sinusitis. JAMA 1995; 273: 1015–1021
48. Arason VA, Kristinsson KG, Sigurdsson JA, Stefandottir G, Molstad S, Gudmundsson S. Do antimicrobials increase thec arriage rate of penicillin resistant pneumococci in children? Cross sectionalp revalence study. BMJ 1996; 313: 387–391
49. Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistancei n group A streptococci. Clin Infect Dis 1995; 21: 1378–1385
50. Nissinen A, Gronroos P, Huovinen P, Herva E, Katila ML, Klaukka T, et al. Development of beta-lactamase-mediated resistance top enicillin in middle-ear isolates of Moraxella catarrhalis in Finnishc hildren, 1978-1993. Clin Infect Dis 1995; 21: 1193–1196
51. Hansen JG, Schmidt H, Rosborg J, Lund E. Predictinga cute maxillary sinusitis in a general practice population. BMJ 1995; 311: 233–236
52. Lindbaek M, Hjortdahl P, Johnsen UL. Use of symptoms,s igns, and blood tests to diagnose acute sinus infections in primary care:c omparison with computer tomography. Fam Med 1996; 28: 183–188